Researcher use AI to predict Alzheimer's disease progression

Researchers at Unlearn.AI, a startup that designs software tools for clinical research, think that artificial intelligence has a valuable role to play in personalizing diagnosis and treatment.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

Embracing Innovation to Move Forward

Podcasts

Your Digital Twin - UnlearnAI

Podcasts

Using AI Digital Twins for Drug Testing

Dr. Charles Fisher, CEO of Unlearn AI, discusses creating digital clones by using artificial intelligence for use in clinical drug trials.
A fascinating approach to the problem of how to make clinical trials more efficient, and understand more about what may be possible with more and better patient data.
At Unlearn, our goal is to use the data available from historical trials, to generate new evidence to inform and advance research.